Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // March 31st, 2008 // 6:54 am
Welcome to the working week. Although for many of us, this may feel a bit like mid-week, given the hoopla yesterday over Vytorin, which you can read about in the posts below this one. In any event, remember what the morning mayor said: Every brand new day should be unwrapped like a precious gift. So grab your cup of stimulation and take a peek at these…
Teva To Pay $360M To Buy Bentley Pharma (MarketWatch)
South Korean Group Wants Lower Price For Gleevec (Trading Partners)
UK Docs May Be Required To Release Scrip Details (The Financial Times)
Biotechs And Venture Capitalists Spar Over SBA Program (Dallas Business Journal)
BPH Ads Didn’t Help Device Makers (St. Paul Pioneer-Press)